Literature DB >> 29151579

TLR5: beyond the recognition of flagellin.

Jingyi Yang1, Huimin Yan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29151579      PMCID： PMC5719140          DOI： 10.1038/cmi.2017.122

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  17 in total

1.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.

Authors:  F Hayashi; K D Smith; A Ozinsky; T R Hawn; E C Yi; D R Goodlett; J K Eng; S Akira; D M Underhill; A Aderem
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

2.  Frontline Science: Nasal epithelial GM-CSF contributes to TLR5-mediated modulation of airway dendritic cells and subsequent IgA response.

Authors:  Yuan Cao; Ejuan Zhang; Jingyi Yang; Yi Yang; Jie Yu; Yang Xiao; Wei Li; Dihan Zhou; Yaoming Li; Bali Zhao; Hu Yan; Mengji Lu; Maohua Zhong; Huimin Yan
Journal:  J Leukoc Biol       Date:  2017-05-18       Impact factor: 4.962

3.  Airway epithelial expression of TLR5 is downregulated in healthy smokers and smokers with chronic obstructive pulmonary disease.

Authors:  Rui Wang; Joumana Ahmed; Guoqing Wang; Ibrahim Hassan; Yael Strulovici-Barel; Jacqueline Salit; Jason G Mezey; Ronald G Crystal
Journal:  J Immunol       Date:  2012-08-01       Impact factor: 5.422

4.  Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade.

Authors:  Zhen-Zhong Xu; Yong Ho Kim; Sangsu Bang; Yi Zhang; Temugin Berta; Fan Wang; Seog Bae Oh; Ru-Rong Ji
Journal:  Nat Med       Date:  2015-10-19       Impact factor: 53.440

5.  Toll-like receptor 5 in obesity: the role of gut microbiota and adipose tissue inflammation.

Authors:  Satu Pekkala; Eveliina Munukka; Lingjia Kong; Eija Pöllänen; Reija Autio; Christophe Roos; Petri Wiklund; Pamela Fischer-Posovszky; Martin Wabitsch; Markku Alen; Pentti Huovinen; Sulin Cheng
Journal:  Obesity (Silver Spring)       Date:  2015-01-22       Impact factor: 5.002

Review 6.  Immune surveillance by the liver.

Authors:  Craig N Jenne; Paul Kubes
Journal:  Nat Immunol       Date:  2013-09-18       Impact factor: 25.606

7.  Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice.

Authors:  Benoit Chassaing; Ruth E Ley; Andrew T Gewirtz
Journal:  Gastroenterology       Date:  2014-08-27       Impact factor: 22.682

8.  Lung epithelial MyD88 drives early pulmonary clearance of Pseudomonas aeruginosa by a flagellin dependent mechanism.

Authors:  Adam A Anas; Miriam H P van Lieshout; Theodora A M Claushuis; Alex F de Vos; Sandrine Florquin; Onno J de Boer; Baidong Hou; Cornelis Van't Veer; Tom van der Poll
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-10       Impact factor: 5.464

9.  Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist.

Authors:  Lyudmila G Burdelya; Craig M Brackett; Bojidar Kojouharov; Ilya I Gitlin; Katerina I Leonova; Anatoli S Gleiberman; Semra Aygun-Sunar; Jean Veith; Christopher Johnson; Gary J Haderski; Patricia Stanhope-Baker; Shyam Allamaneni; Joseph Skitzki; Ming Zeng; Elena Martsen; Alexander Medvedev; Dmitry Scheblyakov; Nataliya M Artemicheva; Denis Y Logunov; Alexander L Gintsburg; Boris S Naroditsky; Sergei S Makarov; Andrei V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

10.  Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis.

Authors:  Craig M Brackett; Bojidar Kojouharov; Jean Veith; Kellee F Greene; Lyudmila G Burdelya; Sandra O Gollnick; Scott I Abrams; Andrei V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205
View more
  20 in total

Review 1.  Toll-Like Receptor Signaling in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Innate Immune Responses and the Potential Application Value of Toll-Like Receptor Immunomodulators in Patients With Coronavirus Disease 2019.

Authors:  Jiayu Dai; Yibo Wang; Hongrui Wang; Ziyuan Gao; Ying Wang; Mingli Fang; Shuyou Shi; Peng Zhang; Hua Wang; Yingying Su; Ming Yang
Journal:  Front Microbiol       Date:  2022-06-27       Impact factor: 6.064

Review 2.  Toll-like receptors in mediating pathogenesis in systemic sclerosis.

Authors:  L Frasca; R Lande
Journal:  Clin Exp Immunol       Date:  2020-02-21       Impact factor: 4.330

Review 3.  Factors influencing the immunogenicity of influenza vaccines.

Authors:  Simin Wen; Zhengyu Wu; Shuyi Zhong; Mao Li; Yuelong Shu
Journal:  Hum Vaccin Immunother       Date:  2021-03-11       Impact factor: 3.452

4.  Anesthetics isoflurane and sevoflurane attenuate flagellin-mediated inflammation in the lung.

Authors:  Koichi Yuki; Yusuke Mitsui; Miho Shibamura-Fujiogi; Lifei Hou; Kirsten C Odegard; Sulpicio G Soriano; Gregory P Priebe; Sophia Koutsogiannaki
Journal:  Biochem Biophys Res Commun       Date:  2021-04-21       Impact factor: 3.322

5.  Divergent Roles of Kupffer Cell TLR2/3 Signaling in Alcoholic Liver Disease and the Protective Role of EGCG.

Authors:  Pingping Luo; Fei Wang; Nai-Kei Wong; Yi Lv; Xinxin Li; Mianhuan Li; George L Tipoe; Kwok-Fai So; Aimin Xu; Shuaiyin Chen; Jia Xiao; Hua Wang
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-09-25

Review 6.  Gut microbiota associations with metabolic syndrome and relevance of its study in pediatric subjects.

Authors:  Ana K Carrizales-Sánchez; Tomás García-Cayuela; Carmen Hernández-Brenes; Carolina Senés-Guerrero
Journal:  Gut Microbes       Date:  2021 Jan-Dec

Review 7.  Host factors: Implications in immunopathogenesis of COVID-19.

Authors:  Roghayeh Jafarpour; Salar Pashangzadeh; Razieh Dowran
Journal:  Pathol Res Pract       Date:  2021-10-12       Impact factor: 3.250

Review 8.  Helicobacter pylori Outer Membrane Vesicles and Extracellular Vesicles from Helicobacter pylori-Infected Cells in Gastric Disease Development.

Authors:  María Fernanda González; Paula Díaz; Alejandra Sandoval-Bórquez; Daniela Herrera; Andrew F G Quest
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

9.  Analysis of substitution rates showed that TLR5 is evolving at different rates among mammalian groups.

Authors:  Ana Pinheiro; Ana Águeda-Pinto; José Melo-Ferreira; Fabiana Neves; Joana Abrantes; Pedro J Esteves
Journal:  BMC Evol Biol       Date:  2019-12-02       Impact factor: 3.260

10.  A first-in-human study of KMRC011, a potential treatment for acute radiation syndrome, to explore tolerability, pharmacokinetics, and pharmacodynamics.

Authors:  Eunsol Yang; Hyejung Choi; Jin-Sol Park; Young-Woock Noh; Chi-Min Choi; Woo-Jong Lee; Jae-Wook Ko; Jungryul Kim
Journal:  Clin Transl Sci       Date:  2021-06-10       Impact factor: 4.689
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.